If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,778.00    -2.00 (-0.05%)
Bid:
3,762.00
Ask:
3,780.00
Spread: 18.00 (0.478%)
Market Cap: £1.06b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Result of AGM

22 May 2024 15:25

RNS Number : 5194P
4imprint Group PLC
22 May 2024
 

22 May 2024

 

4imprint Group plc

Results of Annual General Meeting 2024

 

All of the resolutions proposed at the Annual General Meeting of 4imprint Group plc ("4imprint") held at 11.00 a.m. on Wednesday 22 May 2024 were duly passed and the results of the poll on all resolutions passed at the AGM are set out in the table below.

 

Each Shareholder, present in person or by proxy, was entitled to one vote per share held.

 

FOR*

%

AGAINST

%

WITHHELD**

1

Receipt of Financial Statements

23,430,344

100.00

700

0.00

69,109

2

Directors' Remuneration Report

21,811,488

92.82

1,688,139

7.18

516

3

Directors' Remuneration Policy

22,476,596

95.65

1,023,107

4.35

440

4

Approval of Long Term Incentive Plan

22,787,667

96.97

712,476

3.03

0

5

Approval of final dividend

23,500,143

100.00

0

0.00

0

6

Re-election of Director - Lindsay Claire Beardsell

22,731,136

98.63

316,546

1.37

452,461

7

Re-election of Director - John Michael Gibney

22,732,167

96.73

767,900

3.27

76

8

Re-election of Director - Kevin Lyons-Tarr

23,498,727

99.99

1,341

0.01

75

9

Re-election of Director - Paul Stephen Moody

22,479,498

97.53

568,185

2.47

452,460

10

Re- election of Director - Jaz Rabadia Patel

23,091,314

98.26

408,753

1.74

76

11

Re-election of Director - David John Emmott Seekings

23,452,037

99.80

48,051

0.20

75

12

Re-election of Director - Christina Dawn Southall

22,331,021

95.03

1,169,065

4.97

77

13

Re-appointment of Auditors

23,008,512

98.06

454,984

1.94

36,667

14

Remuneration of Auditors

23,462,604

100.00

1,004

0.00

36,555

15

Directors' authority to allot shares***

23,390,642

99.53

109,521

0.47

0

16

Disapplication of Pre-emption rights***

22,789,310

96.98

710,778

3.02

75

17

Authority to purchase own shares***

23,024,564

98.06

454,986

1.94

20,613

18

Notice of General Meeting***

22,901,141

97.45

599,018

2.55

4

 

* Includes discretionary votes. 

 ** A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

 *** Indicates Special Business.

 

The total number of Ordinary Shares in issue, excluding Treasury Shares, on 22 May 2024 is 28,172,530. 

 

A copy of the resolutions passed as special business at today's Annual General Meeting will, in accordance with Listing Rule 9.6.2, be submitted to the National Storage Mechanism.

 

 

Emma Taylor

Company Secretary

4imprint Group plc

Tel: + 44 (0) 20 3709 9680

E-mail: agm@4imprint.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUUUSRSSUVUAR
Date   Source Headline
30th Jun 20267:00 amRNSHolding(s) in Company
29th Jun 20261:40 pmRNSBlock Listing Interim Review
9th Jun 20261:58 pmRNSHolding(s) in Company
4th Jun 20267:00 amRNSDirector/PDMR Shareholding
20th May 20261:14 pmRNSResult of AGM
20th May 20267:00 amRNSAGM Statement
15th May 20268:02 amRNSDirector/PDMR Shareholding
14th Apr 20269:27 amRNSAnnual Financial Report
25th Mar 20262:05 pmRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSFinal Results
11th Mar 20267:00 amRNSFinal Results
18th Feb 20267:00 amRNSHolding(s) in Company
10th Feb 20262:54 pmRNSHolding(s) in Company
22nd Jan 20268:54 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
5th Jan 20262:39 pmRNSBlock listing Interim Review
22nd Dec 20252:41 pmRNSHolding(s) in Company
22nd Dec 20252:41 pmRNSHolding(s) in Company
3rd Dec 20257:00 amRNSChair Succession
11th Nov 20257:00 amRNSTrading Statement
24th Oct 20258:31 amRNSHolding(s) in Company
21st Oct 20254:04 pmRNSHolding(s) in Company
29th Aug 20253:52 pmRNSHolding(s) in Company
29th Aug 20257:41 amRNSHolding(s) in Company
29th Aug 20257:35 amRNSHolding(s) in Company
6th Aug 20257:00 amRNSHalf-year Report
23rd Jul 20259:09 amRNSBlock listing Interim Review
4th Jun 20258:31 amRNSDirector/PDMR Shareholding
21st May 20251:02 pmRNSResult of AGM
21st May 20257:00 amRNSAGM Statement
2nd May 20253:47 pmRNSDirector/PDMR Shareholding
2nd May 20257:47 amRNSChange of Adviser
15th Apr 20259:30 amRNSDoc re Report and Accounts
3rd Apr 20252:09 pmRNSHolding(s) in Company
28th Mar 20258:44 amRNSEBT Purchase
27th Mar 20258:08 amRNSDirector/PDMR Shareholding
21st Mar 20258:09 amRNSEBT Purchase
12th Mar 20257:00 amRNSDirectorate Change
12th Mar 20257:00 amRNSFinal Results
4th Mar 20254:06 pmRNSHolding(s) in Company
21st Jan 20257:00 amRNSTrading Statement
17th Dec 20242:53 pmRNSDirector/PDMR Shareholding
6th Dec 20249:03 amRNSHolding(s) in Company
5th Dec 20242:58 pmRNSEBT Purchase
14th Nov 20241:57 pmRNSHolding(s) in Company
12th Nov 20247:00 amRNSTrading Statement
7th Nov 20243:00 pmRNSHolding(s) in Company
6th Nov 20249:55 amRNSHolding(s) in Company
29th Oct 20241:29 pmRNSHolding(s) in Company
21st Oct 20248:32 amRNSEBT Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.